Literature DB >> 11584355

Hepatitis B e antigen-negative chronic hepatitis B.

S J Hadziyannis1, D Vassilopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11584355     DOI： 10.1053/jhep.2001.27834

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  110 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Current status of antiviral therapy for hepatitis B.

Authors:  Daryl T-Y Lau; Wissam Bleibel
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

Review 3.  Resistance to lamivudine therapy: is there more than meets the eye?

Authors:  G Dusheiko; A Bertoletti
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 4.  Peginterferon-alpha-2a (40kD): a review of its use in the management of patients with chronic hepatitis B.

Authors:  Gayle W Robins; Lesley J Scott; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Management of patients with HBeAg-negative chronic hepatitis B.

Authors:  Nripen Saikia; Rupjyoti Talukdar; Subhasish Mazumder; Sudeep Khanna; Rakesh Tandon
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

Review 6.  Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Authors:  L H Calabrese; N N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

7.  Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections.

Authors:  Ruy M Ribeiro; Georgios Germanidis; Kimberly A Powers; Bertrand Pellegrin; Paul Nikolaidis; Alan S Perelson; Jean-Michel Pawlotsky
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

8.  Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients.

Authors:  M G Rumi; F De Filippi; C La Vecchia; M F Donato; S Gallus; E Del Ninno; M Colombo
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

9.  Abnormal immunity and gene mutation in patients with severe hepatitis-B.

Authors:  Jing-Yan Wang; Pei Liu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 10.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.